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ABSTRACT

Qualitative transcriptional regulatory sequences functional
in plants, plant tissue and in plant cells for inducible gene

expression and quantitative transcriptional regulatory
sequences for increasing the transcriptional expression of
downstream genetic information in plants, plant tissue and
plant cells are disclosed. Also disclosed are methods and

recombinant DNA molecules for improving the disease
resistance of transgenic plants, especially Wherein an induc
ible promoter controls the expression of a protein capable of
evoking the hypersensitive response in a plant.

91:10445—10449, 1994.
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PATHOGEN-INDUCIBLE REGULATORY
ELEMENT

tobacco plants has been shoWn to be induced by cell Wall

fragments of certain Phytophthora species and by Tricho
derma viride cellulase but not Aspergillus japonicum pec

CROSS REFERENCE TO RELATED
APPLICATIONS

tolyase [Chappell et al. (1991) Plant Physiol. 97:693—698].
Attack by other plant pathogens or an avirulent related strain

can also induce phytoalexin synthesis; for example,

This application is a continuation-in-part of Ser. No.
08/471,983 ?led on Jun. 6, 1995, noW abandoned, Which is

Pseudomonas lachrymans induces sesquiterpenoid synthe
sis in tobacco [Guedes et al. (1982) Phytochemistry

a continuation of Ser. No. 08/443,639, Which Was ?led on

May 18, 1995, the disclosures of Which are hereby incor

porated by reference.

21:2987—2988].
10

the HR in tobacco plants. Amino acid and nucleotide coding
sequences for an elicitin of Phytophthora parasitica have

STATEMENT AS TO FEDERALLY SPONSORED
RESEARCH

This invention Was made, at least in part, With funding
from the National Science Foundation and the United States

15

induce HR and thereby disease resistance; representative
bacteria eliciting HR include, but are not limited to, Agro
20

strains as Well) also induce the HR response, Where these
include, but are not limited to, Phytophthora parasitica and

Peronospora tabaci.

response to the stress of an invading microbial pathogen, an

2. The Background of the Invention
In plants, disease resistance to fungal, bacterial, and viral
pathogens is associated With a plant response termed the
hypersensitivity response
In the HR, the site in the

25

phytoalexins (antibiotics) and/or lytic enZymes capable of
averting pathogen ingress and/or cell Wall modi?cations
Which strengthen the plant cell Wall against physical and/or
enZymatic attack.

How of common biosynthetic precursors into sterols. The

concomitant induction of sesquiterpene cyclase gene expres
sion causes the How of precursors into sesquiterpenes. The
30

deduced amino acid sequence for one member of the EAS
35

gene family of tobacco have been published [Facchini and
Chappell (1992) Proc. Natl. Acad. Sci. USA
89:11088—11092]. The transcriptional expression of one or
more members of the EAS gene family is induced in
response to elicitors.

40

There is a long felt need in the art for methods of

protecting plants, particularly crop plants, from infection by
plant pathogens, including but not limited to, phytopatho
genic viruses, fungi and/or bacteria. Especially important

toalexin production as part of the response to invading

microorganisms. One class of compounds made by tobacco
(Nicotiana tabacum) in response to microbial invaders are

?rst step in the pathWay from farnesyl diphosphate to the

sesquiterpene phytoalexin capsidiol in elicitor-induced
tobacco tissue is catalyZed by 5-epi-aristolochene synthase
(EAS), a sesquiterpene cyclase. The coding sequence and

The HR of plants, including tobacco, can include phy

the antimicrobial sesquiterpenes.
Cell suspension cultures have provided useful informa
tion regarding the regulation of terpene synthesis. Iso
prenoids are ubiquitous in nature, and the early portions of
the biosynthetic pathWay are shared With the biosynthetic
pathWay for other isoprenoid compounds such as sterols,

When tobacco cell suspension cultures are treated With an

elicitor, squalene synthetase is suppressed, thus stopping the

plant Where the potential phytopathogen invades undergoes
localiZed cell death, and it is postulated that this localiZed
plant cell death aspect of the HR contains the invading
microorganism or virus, thereby protecting the remainder of
the plant. Other plant defenses include the production of

bacterium species, Xanthomonas species and Pseudomonas

syringae. Plant pathogenic fungi (and certain avirulent

biology, and it relates in particular to transcription regulatory
elements: a qualitative regulatory sequence Which positively
regulates doWnstream gene expression in plant tissue in
elicitor, or other inducing chemical signals and quantitative
regulatory sequences Which increase the transcriptional
expression of associated sequences.

been published [Kamoun et al. (1993) Mol. Plant-Microbe
Interactions 6:573—581]. Plant pathogenic viruses including,
but not limited to, Tobacco Mosaic Virus (TMV) induce the
HR in infected plants. Bacteria Which infect plants also can

Department of Agriculture. Accordingly, the United States
Government may have certain rights in this invention.
1. The Field of the Invention
The ?eld of this invention is the area of plant molecular

Elicitins are proteins Which are produced by plant patho
gens and potential plant pathogens, Which proteins induce

45

from the standpoint of economics and environmental con
cerns are biological or “natural” methods rather than those

Which depend on the application of chemicals to crop plants.
There is also a long felt need in the art for plant transcrip
tional regulatory sequences for use in controlling the expres

sion of heterologous DNA sequences in transgenic plants.

carotenoids, dolichol, and ubiguinone and groWth regulators

SUMMARY OF THE INVENTION

(e.g., gibberellic acid), Which are classi?ed as primary
metabolites. Isoprenoid compounds classi?ed as secondary

In general, the invention features a recombinant nucleic
acid molecule that includes an inducible plant disease
resistance regulatory element. Such a recombinant nucleic
acid molecule is, in general, at least 80% identical to a

metabolites are not essential for groWth, and include mono-,

55

sesqui-, and diterpenoids. These secondary metabolite iso
prenoids are important mediators of interactions betWeen the
plant and its environment.
A variety of compositions can serve as elicitors of plant
phytoalexin synthesis. These include, but are not limited to,

naturally-occurring inducible plant disease-resistance regu
latory element; that is, up to 20% of the base pairs of the
reference DNA sequence can be replaced With an alternative
60

basepair (e.g., G-C replaced With A-T, T-A, or C-G), pro
vided that the transcription-promoting activity of the altered

one or more toxic ions, e.g., mercuric ions, other chemically

de?ned compositions, metabolic inhibitors, cell Wall

sequence is the same or greater than the reference sequence.

glycans, certain glycoproteins, certain enZymes, fungal
spores, chitosans, certain fatty acids, and certain oligosac

In preferred embodiments, the recombinant nucleic acid

charides derived from plant cell Walls [See, e.g., Sequeira, L.
(1983) Annu. Rev. Microbiol. 37:51—79 and references cited

therein]. Epi-5-aristolochene synthase (EAS) activity in

molecule according to the invention is obtained from a gene
65

encoding a terpene cyclase (e.g., a sesquiterpene cyclase).
For example, the recombinant regulatory element of the
invention is obtained from an epi-5-aristolochene synthase

6,100,451
3

4

(EAS) gene that includes the nucleotide sequence shown in
FIG. 3A (SEQ ID NO: 14) or an inducible plant disease

including the nucleic acid of invention positioned for
increasing transcription of a doWnstream DNA sequence and
integrated into the genome of the transgenic plant cell; and

resistance fragment thereof. In preferred embodiments, the
recombinant nucleic acid molecule according to the inven
tion has the nucleotide sequence shoWn in FIG. 3A (SEQ ID

(b) groWing the transgenic plant from the plant cell.

NO: 14).

provides qualitative transcriptional regulatory sequences

In addition to the above features, the present invention

Which regulate doWnstream gene expression in plant tissue

In other preferred embodiments, the nucleic acid mol
ecules of the invention includes any of the folloWing
sequences: nucleotides 463—473 of SEQ ID NO: 2; nucle
otides 406—486 of SEQ ID NO: 2; nucleotides 463—572 of
SEQ ID NO: 2; nucleotides 371—463 of SEQ ID NO: 2; and
nucleotides 411—457 of SEQ ID NO: 2.
In preferred embodiments, the recombinant nucleic acid

10

molecule of the invention is obtained from a dicot (e.g., a
member of the Solanaceae such as Nicotiana). In other

15

in response to one or more elicitors, other de?ned inducing
compounds, or in response to the stress of an invading

phytopathogen (the inducible transcription regulatory
sequence) and quantitative transcription regulatory
sequences Which increase the transcription of doWnstream

sequences (the transcription-enhancing sequence). As spe

ci?cally exempli?ed herein, these transcriptional regulatory
sequences are found in nature upstream and operatively

linked to the epi-5-aristolochene synthase gene (EAS4) of
tobacco; When operatively linked to a coding sequence (and
in the presence of an operatively linked promoter element,

preferred embodiments, the nucleic acid of the invention is
obtained from a monocot; a gymnosperm; or a conifer.

In yet other preferred embodiments, the nucleic acid
molecule of the invention is genomic DNA; chemically

from the EAS4 gene or from a heterologous plant

expressible gene) these sequences mediate the inducible
transcriptional expression of that coding sequence When the
plant or plant tissue is invaded by a potential phytopathogen

synthesiZed DNA; or is a combination of genomic DNA and

chemically-synthesized DNA; genomic DNA and cDNA;
chemically-synthesized DNA and cDNA; or genomic DNA,
cDNA, and chemically-synthesized DNA.
In preferred embodiments, induction of the nucleic acid

(e.g., a virus, fungus or bacterium) or in response to elicitors
such as Trichoa'erma viride cellulase or plant or fungal cell

Wall fragments for plants, plant tissue and/or plant suspen

molecule of the invention is mediated by a plant pathogen
such as a fungus (e.g., Phytophthora), a bacterium (e.g.,
Pseudomonas), or a virus (e.g., tobacco mosaic virus) as
described herein. In other preferred embodiments, such
induction is mediated by an elicitor (e.g., by fungal or

sion culture cells. That potential plant pathogen can be a
virus including, but not limited to, tobacco mosaic virus or
tobacco vein mottle virus; a bacterium including, but not

bacterial elicitors).

not limited to, a species of Phytophthora (e.g., R parasitica)
or Peronospora (e.g., R tabaci). The EAS4 promoter includ

limited to, Pseudomonas syringae, Xanthomonas campestris
or Agrobacterium tumefaciens; or a fungus including, but

In another aspect, the nucleic acid molecule of invention
is operably linked to and functions to regulate inducible
transcription of nucleotide sequences encoding a heterolo

gous polypeptide. Preferably, the heterologous polypeptide
is capable of conferring disease-resistance to a plant. For
example, the heterologous polypeptide may be an elicitin
(e.g., a fungal elicitin such as the parAl polypeptide from

ing the inducible transcription regulatory element(s) and the
transcription-enhancing sequence(s) are disclosed herein as
35

Phytophthora, a bacterial elicitin such as harpin, or a phar

Examples of inducible transcriptional regulatory elements

maceutical polypeptide such as tissue plasminogen

Within the N. tabacum EAS4 upstream sequence are from
nucleotide 458 to nucleotide 473 of SEQ ID NO:2; from
nucleotide 454 to 473; and from nucleotide 413 to 473 of
SEQ ID NO:2.

activator). Expression of such a heterologous polypeptide is
mediated by one or more external agents (e.g., ethylene or

methyl jasmonate). In other embodiments, the nucleic acid
molecule of invention is capable of expressing the heterolo
gous polypeptide in a cell-speci?c manner.
In another aspect, the invention features a vector includ
ing the nucleic acid molecule of the invention, a method of

45

Another aspect of the present invention is the
transcription-enhancing element derived from the EAS4
promoter and promoter-associated sequences. When opera
tively linked upstream of a initiation sequences and a

directing expression of a polypeptide by introducing the

heterologous DNA sequence to be expressed.
Further aspects of the present invention are transgenic

vector into a cell (e.g., a transgenic plant cell), and a cell
containing the vector.
In another aspect, the invention features a method of
providing disease-resistance to a transgenic plant, the

method including the steps of: (a) producing a transgenic
plant cell including the nucleic acid of according to the
invention integrated into the genome of the transgenic plant

SEQ ID NO:2. In SEQ ID NO:2, the CAAT-homologous
sequence of the EAS4 promoter is located at nucleotides 513
to 516, and the TATA-sequence motif is located at nucle
otides 540 to 543.

plant cells, plant tissues, and plants Which have been geneti
cally engineered to contain and express a nucleotide
sequence of interest, preferably a coding sequence, an
antisense sequence, or other sequence under the regulatory

control of the inducible transcription regulatory element. It
55

cell; and (b) groWing the transgenic plant from the plant cell
Wherein the expression of the nucleic acid molecule accord
ing to the invention confers disease-resistance to the trans

genic plant.

is an object of this invention to provide the nucleotide
sequences Which mediate the induction of the expression of
a doWnstream coding sequence in response to elicitor
exposure, potential phytopathogen invasion in a plant, or
certain other exogenous inducing signals such as exposure to

In preferred embodiments, the transgenic plant according

methyl jasmonate and ethylene. An exemplary elicitor

to the methods of the invention is a dicot (e.g., is a member
of the Solanaceae such as Nicotiana); a monocot; a gymno

inducible transcription regulatory element is that from the 5 ‘
?anking region of the EAS4 gene of Nicotiana tabacum; as

speci?cally exempli?ed herein, this sequence is presented in

sperm; or a conifer.

SEQ ID NO:2 from nucleotide 410 to nucleotide 473.

In another aspect, the invention features a method of

increasing the transcriptional expression of a doWnstream
DNA sequence in a transgenic plant cell, the method includ

ing the steps of: (a) producing a transgenic plant cell

65

Equivalents of the exempli?ed nucleotide sequence are
those nucleotide sequences Which similarly direct the induc
tion of the expression of doWnstream nucleotide sequences.

6,100,451
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Preferably, the inducible transcription regulatory element is

gene to the reporter gene. To test for complete promoters, the

associated With the EAS4 promoter and promoter-associated
sequences (e.g., the combination having the nucleotide

DNA fragment is placed directly in front of the reporter gene

sequence as given in SEQ ID NO:2 from nucleotide 410 to

techniques, any fragment of an inducible plant disease
resistance regulatory element may be identi?ed.

lacking endogenous promoter activity. Using such

nucleotide 573 of SEQ ID NO:2, preferably from nucleotide
361 to 573 of SEQ ID NO:2, and more preferably from
nucleotide 1 to 573 of SEQ ID NO:2).
By “disease-resistance regulatory element” is meant a

DNA sequence capable of regulating the expression of a
gene product associated With a plant defense response (e.g.,
a hypersensitive response) that, in a native plant, is used to
a combat pathogenic organism. Also included in this term
are regulatory elements (and, as de?ned beloW, fragments of
such regulatory elements) that are sufficient to render gene

expression inducible by disease-associated external signals

By “tissue-speci?c” is meant capable of preferentially
increasing expression of a gene product (e.g., an mRNA
molecule or polypeptide) in one tissue (e. g., xylem tissue) as
10

compared to another tissue (e.g., phloem).
By “cell-speci?c” is meant capable of preferentially
increasing expression of a gene product (e.g., an mRNA
molecule or polypeptide) in one cell (e.g., a parenchyma

cell) as compared to another cell (e.g., an epidermal cell).
15

By “epi-5-aristocholene synthase” or “EAS” is meant an

or agents (e.g., pathogen- or elicitor-induced signals or

enZyme capable of catalyZing the cycliZation of trans, trans

agents as described herein). In general, disease-resistance

farnesyl diphosphate to the bicyclic intermediate epi-5

regulatory elements are located in the 5‘ region of a gene, but

aristocholene.
By “pathogen” is meant an organism Whose infection into
the cells of viable plant tissue elicits a disease response in

are not so limited.

By “inducible” is meant that a regulatory element is

20

capable of mediating increased gene expression (e.g.,

the plant tissue.

mRNA or polypeptide production) in response to an inter
action betWeen a plant cell and either a pathogen or elicitor.
Also included in the invention are disease-resistance regu

By “elicitor” is meant any molecule that is capable of
initiating a plant defense response. Examples of elictors

latory elements that direct inducible gene expression in a

include, Without limitation, one or more toxic ions, e.g.,
25

cell- or tissue-speci?c manner.

By “obtained from a gene” is meant that the nucleotide
sequence of a regulatory element is based on sequence

Walls, and elicitins (e.g., harpin, cryptogein, and pariscein).

information included in a naturally-occurring plant gene

(e.g., tobacco EAS4). Once identi?ed, the regulatory ele

mercuric ions, other chemically de?ned compositions, meta
bolic inhibitors, cell Wall glycans, certain glycoproteins,
certain enzymes, fungal spores, chitosans, certain fatty
acids, and certain oligosaccharides derived from plant cell

30

By “elicitin” is meant a protein elicitor.
By “operably linked” is meant that a regulatory sequence

ment according to the invention is obtained from a natural
source or can be prepared according to any standard method

(s) and a gene are connected in such a Way as to permit gene

(e.g., by recombinant methods or chemical synthesis). Such

expression When the appropriate molecules (e.g., transcrip

a recombinant nucleic acid molecule is, in general, at least
80% identical to a naturally-occurring inducible plant
disease-resistance regulatory element; that is, up to 20% of
the base pairs of the reference DNA sequence can be

tional activator proteins) are bound to the regulatory
35

By “heterologous polypeptide” is meant any polypeptide
that is expressed in a transformed plant cell from a gene that

replaced With an alternative basepair (e.g., G-C replaced
With A-T, T-A, or C-G), provided that the transcription
promoting activity of the altered sequence is the same or
greater than the reference sequence.

sequence(s).
is partly or entirely foreign (i.e., does not naturally occur in)

40

to the transformed plant cell.
By “polypeptide” is meant any chain of amino acids,

regardless of length or post-translational modi?cation (e.g.,
glycosylation or phosphorylation).

By “an inducible plant disease-resistance fragment” is
meant any stretch of nucleotides regardless of length, Which
is suf?cient to direct increased gene expression (e.g., mRNA

By “transformed plant cell” is meant a cell into Which (or
into an ancestor of Which) a recombinant nucleotide

or polypeptide production) in response to an interaction 45
sequence (e.g., the EAS4 promoter(—1147 to +67): GUS
betWeen a plant cell and either a pathogen or elicitor. The
reporter gene or gEAS46O0(cyclase) promoter:parA1 mature
term “fragment” preferably means about 6—10 nucleotides in

elicitin gene) has been introduced by means of recombinant

length. HoWever, fragments of DNA regulatory elements

DNA techniques (e.g., those techniques described herein).

according to the invention can range in siZe from 10—100
nucleotides, 100—300 nucleotides in length, or even greater

By “plant cell” is meant any self-propagating cell
bounded by a semi-permeable membrane and containing a
plastid. Such a cell also requires a cell Wall if further
propagation is desired. Plant cell, as used herein includes,

than 300 nucleotides in length. Such fragments are prepared

by routine methods (e.g., by appropriate restriction digestion
or by chemical synthesis of the fragment). Identi?cation of
an inducible plant disease-resistance DNA fragment in a
gene is carried out using standard methods in the art (e.g.,
those methods described herein). In one particular example,
identi?cation of an inducible plant disease-resistance frag
ment may be carried out using standard promoter deletion
analysis. Aconstruct including a disease-resistance promoter
that confers pathogen-inducible transcription to a reporter
gene to Which it is operably linked may be progressively
deleted by 5‘, 3‘, and/or nested deletions until the effect of a

55

and microspores.
By “transgenic” is meant any cell Which includes a DNA
sequence Which is inserted by arti?ce into a cell and
60

becomes part of the genome of the organism Which develops
from that cell. As used herein, the transgenic organisms are

generally transgenic plants, and the DNA is inserted by
arti?ce into the genome of the organism.

pathogen on the reporter gene is diminished or eliminated.

To con?rm the identi?cation of the pathogen-inducible
element, point mutations may then be introduced into the
element. An alternate approach to guage changes in tran
scription is to link the presumed regulatory element from the

Without limitation, algae, cyanobacteria, seeds, suspension
cultures, embryos, meristematic regions, callus tissue,
leaves, roots, shoots, gametophytes, sporophytes, pollen,

By “substantially pure DN ” is meant DNA that is free of
65

the genes or ancillary nucleotides Which, in the naturally
occurring genome of the organism from Which the DNA of
the invention is derived, ?ank the gene or regulatory ele
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ment. The term therefore includes, for example, a recombi
nant DNA Which is incorporated into a vector; into an

Water (as control) and 25 nM of cryptogein Were in?ltrated

autonomously replicating plasmid or virus; or into the

and the in?ltrated Zones of leaf tissue Were then collected for

genomic DNA of a prokaryote or eukaryote; or Which exists

analysis of GUS activity over the 18 hour time course. The
presented data are the averaged results of tWo separate
experiments. FIG. 4B is a bar graph shoWing elicitor
induced GUS activity in the stems and roots of transgenic

symmetrically and simultaneously into the leaf (abaxially),

as a separate molecule (e.g., a cDNA or a genomic or cDNA

fragment produced by PCR or restriction endonuclease
digestion) independent of other sequences. It also includes a
recombinant DNA Which is part of a hybrid gene encoding
an additional polypeptide sequence or a regulatory element.

Other features and advantages of the invention Will be

1O

apparent from the folloWing description of the preferred
embodiments thereof, and from the claims.

E-18 (solid boxes) represent GUS activity in segmented
roots and stems 18 hours after an incubation in Water or 100

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 presents data for transient expression experiments
for GUS regulated by the EAS3 and EAS4 promoter region

15

sequences in comparison to a CaMV 35S-GUS construct

(Cauli?ower Mosaic Virus 35S promoter—[3-glucuronidase
reporter gene). These experiments Were carried out in
tobacco protoplasts into Which the DNA constructs had been
electroporated. “Uninduced” levels of expression for the
EAS-GUS constructs Were relatively high because fungal
enZymes Which digest plant cell Walls Were used in the

preparation of the protoplasts. The y-axis shoWs units of
GUS activity and the 5‘ extents of the EAS upstream
sequences are given beloW each bar on the graph. As above,
the numbering is relative to the natural transcription start site

line of transgenic tobacco (09p) containing the EAS4

25

cultures and then incubated in a groWth chamber at 27° C.
With constant ?uorescent light for 24 hours. Control leaves
Were inoculated With sterile oatmeal agar plugs. Infected
Zones of tissue Were then examined for GUS activity. Values
indicated by each bar are the means and standard errors for

three separate experiments (n=5).
FIG. 6 is a bar graph illustrating the comparison of

(SEQ ID NO:2) a start site is at nucleotide 573; in EAS3
(SEQ ID NO:1) a potential transcription start site is at
nucleotide 489.

pathogen- and elicitor-induced GUS activity in transgenic
plants treated With Pseudomonas Syringae pv. Syringae 61
and its hrpH mutant, and the puri?ed bacterial elicitor
protein harpin. Leaves of one line of transgenic tobacco
(09-P) containing the EAS4 promoter(—1148 to +67): GUS

FIGS. 2A—2B present information concerning the reporter
gene expression directed by the instant inducible transcrip
35

reporter gene Were in?ltrated With either 50 pg/mL of

puri?ed Erwinia amylovora harpin elicitor, cell suspensions

moter region controlling the expression of the GUS reporter
gene in stably transformed transgenic plants. FIG. 2B pre

of Wild type R Syringae pv. Syringae 61 or its hrpH mutant
(A6OO=0.05). After a 12 hour incubation, in?ltrated Zones of
tissue Were subsequently analyZed for GUS activity. Control
values represent GUS activity observed in leaf tissue

sents the results of “gain of function” assays for the EAS4

promoter-associated sequences regulating expression of the
GUS reporter gene via the CaMV 35S minimal promoter. In
both FIGS. 2A and 2B, numbering for the EAS4 upstream
region re?ects numbering relative to the natural transcription
start site of the EAS4 gene (see also SEQ ID NO:2 Wherein
the transcription start site corresponds to nucleotide 573). In
both FIGS. 2A and 2B, the GUS expression is measured in
?uorescence units per milligram of protein.

nM of elicitor cryptogein, respectively. Five independent
plants Were evaluated per transgenic line.
FIG. 5 is a bar graph illustrating pathogen-induced GUS
activity by race 0 and race 1 of Phytophthora parasitica var.
Nicotianae in transgenic tobacco. Detached leaves from one

promoter(—1148 to +67): GUS reporter gene Were inocu
lated With mycelial plugs of 2-day-old P. p. var. Nicotianae

of EAS4 (or the corresponding base of EAS3); in EAS4

tion regulatory element of the invention. FIG. 2A presents a
schematic of experiments carried out With the EAS4 pro

tobacco containing the EAS4 promoter(—1148 to +67): GUS
reporter gene. 03f and 09p represent tWo independently
transformed lines of transgenic tobacco. C-O (open boxes)
represents GUS activity present in segmented roots and
stems Without elicitor treatment. C-18 (shaded boxes) and

samples Which Were in?ltrated With Water. Values indicated
by each bar are the average of results obtained from ?ve

plants.
FIGS. 7A—7B shoW a Western blot analysis of induction
45

of 5-epi-aristolochene synthase (EAS) in tobacco plant
tissues. Proteins Were extracted from control- and elicitor

treated tobacco leaves, stems, and roots. Equal guantities of
proteins (25 pg per lane for leaf and stem, 15 pg per lane for
root) Were separated by SDS-PAGE and transferred to

FIGS. 3A—3B are schematic illustrations shoWing the
DNA sequence of the 5‘ upstream region of the EAS4 gene
and the structure of the GUS reporter gene carrying the
EAS4 promoter(—1148 to +67). FIG. 3A shoWs the nucle
otide sequence of the 5‘ upstream region of the EAS4
promoter (-1148 to +67). The CAAT and TATA boxes are
marked in bold face. The transcription initiation site is

nitrocellulose membranes. The blots Were then reacted With

EAS antiserum and immunoreactive bands visualiZed using
goat anti-mouse antibodies coupled to alkaline phosphatase.

marked as +1. FIG. 3B is a schematic illustration shoWing 55

the structure of the EAS4 promoter(—1148 to +67): GUS
reporter gene. The 5‘ ?anking sequence of the EAS4 pro
moter (-1148 to +67) Was fused in correct reading frame
With the GUS reporter gene in binary vector pBI101.1.
FIGS. 4A—4B present data concerning elicitor-induced
GUS gene expression in leaves, stems, and roots of trans

FIG. 7A shoWs the Western blot analysis of leaf and stem
tissue samples. FIG. 7B shoWs the Western blot analysis of
root tissue samples.
FIGS. 8A—8L are color photographs illustrating the his
tochemical localiZation of elicitor-induced GUS activity in

transgenic tobacco containing the EAS4 promoter(—1147 to
+67): GUS reporter gene. Leaf tissues from one represen
tative line of transgenic tobacco Were in?ltrated With either
25 or 50 nM of the cryptogein elicitor. After an approxi

genic tobacco plants containing the EAS4(—1148 to +67):

mately 8 hour incubation, tissue sections Were stained using

GUS reporter gene. FIG. 4A is a graph illustrating elicitor

1 mM X-gluc(5-bromo-4-chloro-3-indoyl [3-glucuronide)

induced GUS activity in tobacco leaves over an 18 hour time

for analysis of GUS activity. Stem and root segments Were
incubated With Water or 100 nM of the elicitor cryptogein for
approximately 12 hours before staining. FIG. 8A is a color

course. 06i, 08r, and 09p each represent an independently
transformed line of transgenic tobacco containing the EAS4
promoter(—1148 to +67): GUS reporter gene construct.
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photograph shoWing elicitor-induced GUS activity in a
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transgenic tobacco leaf containing the EAS4 promoter(—

DETAILED DESCRIPTION OF THE
INVENTION

1147 to +67): GUS reporter gene after treatment With tWo

elicitor preparations: cryptogein and parasicein, both at

5 -epi-aristolochene synthase (EAS) is a key enZyme in the

concentrations of 25 nM and 50 nM (designated in FIG. 8A
as C25, C50, P25, and P50, respectively). FIG. 8B is a color
photograph of a leaf cross-section shoWing elicitor-induced

synthesis of sesquiterpenoid phytoaleXins, for example, in
solanaceous plants, including but not limited to Nicotiana

species (e.g., tabacum), Capsicum annum and Hyoscyamus

GUS activity after treatment With cryptogein (magni?cation,
75x). FIG. 8C is a color photograph shoWing elicitor

muticus. EAS catalyZes the reaction of farnesyl diphosphate
to (+) gemacrene A to eudesmane carbocation to 5-epi
aristolochene. Other plants, such as the crucifers, also have

induced GUS activity in a cross-section of a stem segment

treated With cryptogein (magni?cation, 7.5x). FIGS. 8D—F
are color photographs shoWing successively higher magni
?cations (15x, 60x, and 75x, respectively) of the GUS

10

sesquiterpene cyclase enZymes.
Treatments Which induce host defensive responses in

stained stem cross-section shoWn in FIG. 8C. FIG. 8G is a

plant tissue or plant cells such as phytoaleXin synthesis

color photograph shoWing a root tip treated With Water and
stained for GUS activity (magni?cation, 60x). FIG. 8H is a

include cell Wall fragments of Phytophthora species and
Trichoderma viride cellulase. HoWever, pectolyase from

color photograph shoWing elicitor-induced GUS activity of

15

a longitudinal section of a root tip treated With cryptogein
(magni?cation, 60x). FIG. SI is a color photograph of a

tobacco cell culture. Elicitors Which induce sesquiterpenoid
phytoaleXin synthesis have been shoWn to function at the

longitudinal section of a root after treatment With Water and

staining for GUS activity (magni?cation, 75x). FIG. SJ is a
color photograph shoWing GUS activity of a longitudinal

Aspergillus japonicum does not function as an elicitor in

20

section of a root treated With cryptogein (magni?cation,
75x). FIG. 8K is a color photograph of a root cross-section
treated With Water and staining for GUS activity

(magni?cation, 95x). FIG. SL is a color photograph shoWing
GUS activity of a cross section of a root treated With 25

cryptogein (magni?cation, 95x). C, denotes cryptogein; P,

level of controlling transcription of key biosynthetic
enZymes [Vogeli and Chappell (1990) Plant Physiol.
94:1860—1866]. Similar patterns have been observed in
other plants, but no transcriptional control sequences Which
mediate gene induction in response to phytopathogen chal
lenge have been described.
Tobacco (N. tabacum) contains an EAS gene family With
some 12—15 members, the coding sequence of EAS4 has

denotes parasicein; c, denotes corteX; ca, denotes cambium;
e, denotes epidermis; p, denotes palisade parenchyma; pe,

been published [Facchini and Chappell (1992) supra].

denotes periderm; ph, denotes phloem; pi, denotes pith

covered that the EAS3 does not appear to be expressed in
response to the elicitor treatment, and surprisingly, the
nucleotide sequences upstream of EAS3 do not appear to
mediate the induction of a reporter gene in a chimeric gene
construct in elicitor-induced transgenic cell culture. It is
noted that the translation start site Was incorrectly identi?ed

parenchyma; s, denotes spongy parenchyma; t, denotes
trichome; X, denotes Xylem; vc, denotes vascular cylinder.
FIG. 9 is a schematic of the genetic manipulations leading
to generation of disease-resistant plants. The coding

HoWever, since that time, the present inventors have dis
30

sequence for the ParA1 elicitin is isolated by PCR so as to

have BamHI and SstI ends. gEAS46OO-GUS-pBI101, Which
directs the eXpression of the GUS reporter gene under the
regulatory control of the EAS promoter, is digested With
BamHI and SstI to release the GUS reporter gene. Then the

BamHI/SstI-digested parA1 amplimer is ligated to the large
fragment produced after digestion of gEAS46O0-GUS

35

Facchini and Chappell (1992) supra is presented in SEQ ID
NO:7, With the deduced amino acid sequence being given in
40

SEQ ID NO:8.
Other aspects of a plant’s defenses against invasion and

infection by a phytopathogenic microorganism include the
hypersensitive response, Which is characteriZed by necrosis,

pBI101 to produce gEAS46O0-parA1-pBI101, from Which
the ParA1 elicitin in plant cells or plant tissue is synthesiZed

i.e., programmed cell death in the localiZed area of attack by
the plant pathogen. Elicitor treatments as described above

after induction With a suitable elicitor.

FIG. 10 is a bar graph illustrating the disease ratings of

independent lines of transgenic tobacco (Nicotiana tabacum

in the 1992 Facchini and Chappell publication. The nucle
otide sequence of a genomic clone of EAS4, as it appears in

45

can also induce the necrotic response.

Elicitins are proteins produced by fungal plant pathogens,

cv. KY160) containing either the parA1 mature elicitin gene
under the control of the gEAS46OO<CWlaSe> promoter gene

Which proteins elicit a hypersensitive response in an infected

1 of Phytophthora parasitica var. nicotianae. The y-aXis
shoWs the lesion score (number of lesions per leaf) after 72
hours. The X-aXis shoWs control plants and independent lines

plant. Generally, but not necessarily, localiZed cell death is
the result of the elicitin-induced response in the infected (or
challenged) plant tissue. These responses mediate full or
partial resistance to destructive infection by the invading,

of transgenic tobacco Which Were tested for disease resis

potentially plant pathogenic microorganism. For the pur

tance. KY160 denotes non-transformed N. tabacum cv.

poses of the present invention, a protein of a plant pathogen

after inoculation of detached leaves With either race 0 or race

or potential plant pathogen Which induces the hypersensitive

KY160; G denotes independent lines of transgenic N.
tabacum cv. KY160 Which Were transformed With a con

55

is considered to fall Within a broad de?nition of an elicitin.

A relatively Well-knoWn elicitin of a plant-pathogenic

cv. KY160 Which Were transformed With a construct con

taining the gEAS460O<CWlaS€> promoter fused to the mature
parA1 elictin coding sequence; S denotes independent lines

response in plant tissue after invasion of that plant tissue or

after eXpression of that coding sequence in the plant tissue

struct containing the gEAS46OO<CWlaSe> promoter fused to
GUS; M denotes independent lines of transgenic N. tabacum

fungus is the ParA1 protein of Phytophthora parasitica. The

promoter fused to a sequence encoding a mature parA1

parA1 locus is a member of a gene family [Ricci et al. (1989)
Eur J. Biochem. 183:555—563]. The coding and amino acid
sequences for the parA1 gene product are described in
Kamoun et al. (1993) Mol. Plant-Microbe Interact. 6:(5):

elictin including a signal sequence. Shaded boX, denotes

573-14 581 and in SEQ ID NOS:12 and 13 herein.

60

of transgenic N. tabacum cv. KY160 Which Were trans

formed With a construct containing the gEAS460O<CWlaS€>
inoculation of detached leaf With race 0 of P. p. var. 65

Other phytopathogen proteins With potential elicitin activ

nicotianae. Solid boX denotes inoculation of detached leaf

ity have been characteriZed as to amino acid sequences and

With race 1 of P. p. var. nicotianae.

other properties [See, e.g., Nespoulous et al. (1992) Planta
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186155 1—557; Huet et al. (1992) Phytochemistry
31:1471—1476; Huet and Pernollet (1992) FEBS Lett.
257:302—306; Kamoun et al. (1993) Mol. Plant-Microbe
Interact. 5:22—33]. Several avirulent genes from pathogenic
bacteria Which correspond to elicitin activity have been
characterized. For example, Keen, N. T. (1990) Annu. Rev.

plant also refers to those progeny of the initial transgenic
plant Which carry and are capable of expressing the heter

ologous coding sequence under the regulatory control of the

qualitative and/or quantitative transcription control
sequences described herein. Seeds containing transgenic
embryos are encompassed Within this de?nition.
When production of a heterologous gene or coding
sequence of interest is desired under conditions of potential

Phytopathol. 24:383—409 has described an avirulence gene

of Fulva fulvia. Hammond-Kosack et al. (1994) Proc. Natl.
Acad. Sci. USA 91:10445—10449 have described the avr

gene of Cladosporium fulvum, Which functions in the same
Way as the R parasitica elicitin.

pathogen invasion or inducer (e.g., elicitor) treatment, that
10

Certain bacterial plant pathogens also express proteins

inducible regulatory sequences, in the same orientation as
the promoter, so that a sense (i.e., functional for translational

With similar effects on the hypersensitivity response as those

expression) mRNA is produced. A transcription termination

of the R parasitica ParA1 elicitin. For the purposes of the

present invention, these proteins fall Within the scope of the
term “elicitin.” Multiple homologs of the avirulence gene
avrBs3 of Xanthomonas campestris pv. vesicatoria have
been detected in otherX. campestris pathovars [Bonas et al.
(1989) Mol. Gen. Genet. 218:127—136; Knoop et al. (1991)
J. Bacteriol. 173:7142—7150] and in other species of Xan

15
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thomonas [De Feyter and Gabriel (1991) Mol. Plant
Microbe Interact. 4:423—432; Hopkins et al. (1992) Mol.
Plant-Microbe Interact. 5:451—459]. The avrD gene of
Pseudomonas syringae pv. tomato can confer avirulence; R

syringae pv. glycinea expresses an altered avrD gene prod
uct [Kobayashi et al. (1990) Mol. Plant-Microbe Interact.

25

3:103—111].
as it applies to creating transgenic plants With improved

mal promoter functional in those plants) that elicitin proteins
must be capable of promoting expression of defense genes
(including but not limited to those genes governing phytoal
exin synthesis, the hypersensitive response and/or localiZed
necrosis) in those plants. Many functional combinations of

30
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introduced into a plant cell or tissue, its presence can be
selected and plant cells or tissue not so transformed Will be

killed or prevented from groWing. Similarly, a heterologous
coding sequence can be expressed under the regulatory
control of the inducible transcription regulatory element or

the transcription-enhancing element in transgenic plant cell
suspension culture, With induction occurring in response to
the addition of an elicitor to the cell culture medium.

sequence or cDNA sequence can be operably linked to a

the antisense orientation) so that the transcribed RNA is
complementary in sequence to the mRNA, and so that the
expression of the antisense molecule is induced in response
to pathogen invasion. In addition, there may be a transcrip
tional termination signal doWnstream of the nucleotides

directing synthesis of the antisense RNA.
40

of programmed cell death or phytoalexin synthesis or the
like. It is also understood that treatment of plant cells or
tissue With compositions such as certain fungal cellulases or

certain plant polysaccharide fragments can also induce the
host defensive (i.e., hypersensitive) response. Such treat

the coding sequence, and a selectable marker Which can be
expressed in a plant, can be covalently linked to the induc
ible expression unit so that after this DNA molecule is

promoter functional in plant cells, but With the orientation of
the coding sequence opposite to that of the promoter (i.e., in

plant and phytopathogen are knoWn to the art, and the skilled
artisan knoWs hoW to test the functioning of a particular

elicitin in a particular plant tissue (or cells) in the turning on

signal functional in a plant cell can be placed doWnstream of

Where inhibition of gene expression is desired in a plant
being invaded by a microbial pathogen, such as a phyto
pathogenic fungus, then either a portion or all of that coding

It is understood that to be useful in the present invention

disease resistance traits using an elicitin coding sequence
expressed under the regulatory control of a pathogen
response transcription regulatory element (and With a mini

coding sequence is operably linked in the sense orientation
to a suitable promoter and under the regulatory control of the

The present inventors have isolated a DNA sequence
Which mediates the inducible expression of a doWnstream
gene in plant cells in response to invasion by a potential
plant pathogen and/or treatment With an elicitor or other

chemical signals. For example, a combination of ethylene
and methyl jasmonate may serve to induce doWnstream gene
45

expression via the qualitative transcription regulatory
sequence. It is understood that there may be a multiplicity of
sequence motifs Within that regulatory sequence, Where

ments are used as models for actual plant pathogen attack or

invasion.

A non-naturally occurring recombinant nucleic acid

individual motifs each respond to one or more distinct

molecule, e.g., a recombinant DNA molecule, is one Which

environmental signal. As speci?cally exempli?ed, this

does not occur in nature; i.e., it is produced either by natural
processes using methods knoWn to the art, but is directed by

transcription-regulating sequence is derived from the EAS4
locus of N. tabacum, and it is given in SEQ ID NO:7. The
deduced amino acid sequence for the EAS protein is given
in SEQ ID NO:8. The open reading frame of the EAS4 gene,

man to produce a desired result or it has been arti?cially

produced from parts derived from heterologous sources,
Which parts may be naturally occurring or chemically syn
thesiZed molecules or portions thereof, and Wherein those
parts have been joined by ligation or other means knoWn to

Which is interrupted by six introns, is provided in SEQ ID
55

the art.

knoWn nucleotide sequences With signi?cant homology.

A transgenic plant is one Which has been genetically
modi?ed to contain and express heterologous DNA
sequences, either as regulatory RNA molecules or as pro

60

teins. As speci?cally exempli?ed herein, a transgenic plant

the inducible transcriptional control sequences of the EAS4
gene of Nicotiana tabacum. As used herein, a transgenic

Organization of the EAS genes in the N. tabacum genome
Was described in Facchini and Chappell (1992) supra using
an EAS probe and Southern hybridiZation experiments.

Under conditions of high stringency, multiple fragments

is genetically modi?ed to contain and express a heterologous
DNA sequence operably linked to and under the regulatory
control of transcriptional control sequences by Which it is

not normally regulated, i.e., under the regulatory control of

NO:7.
A computer search of Genbank for nucleotide sequences
homologous to the SEQ ID NO:2 sequence revealed no

hybridiZed With analysis indicating that there is a gene
family With some 12—16 members in the tobacco genome. In
65

these experiments, hoWever, the probe included the EAS
coding sequence rather than the promoter and promoter
associated regulatory sequences.
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taken from a hydrophilic portion of the EAS amino acid

EAS homologous genes can be identi?ed and isolated

from plant species other than N. tabacum based on signi?
cant degrees of nucleotide sequence homology; i.e.,
DNAzDNA hybridization under conditions of moderate to
high stringency With a tobacco EAS coding sequence probe
alloWs the identi?cation of the corresponding gene from

sequence (SEQ ID NO:8). Monoclonal and polyclonal anti
body production techniques are readily accessible to the art

(See, e.g., Campbell (1994) Monoclonal Antibody Technol
ogy. Laboratory Techniques in Biochemistry and Molecular
Biology, Vol. 13, Burdon and Knippenberg, eds, Elsevier,
Amsterdam; HarloW and Lane (1988) Antibodies: A Labo

other plant species. A discussion of hybridiZation conditions
can be found for example, in Hames and Higgins (1985)
Nucleic Acid Hybridization, IRL Press, Oxford, UK. Gen
erally sequences Which have at least about 70% nucleotide
sequence homology can be identi?ed by hybridiZation under
conditions of moderate stringency. Under such conditions, it
is generally preferred that a probe of at least 100 bases be
used. Most preferably, in the present case, the probe Will be

derived from the coding portion of the EAS4 coding
sequence. Labels for hybridiZation probes can include, but

ratory Manual, Cold Spring Harbor Laboratory, Cold Spring

Harbor,
10

speci?c antibody can be prepared using peptide sequence(s)
from hydrophilic regions of the EAS protein (SEQ ID NO:8)
15

are not limited to, radioactive groups, ?uorescent groups,

and ligands such as biotin to Which speci?c binding partners
(Which are in turn labeled) bind. It is the label Which alloWs
detection of the hybridiZation probe to the target nucleic acid

and technology Well-knoWn in the art.
An inducible transcription regulatory sequence can be
operably linked to any promoter sequence functional in
plants as understood by the skilled artisan; Where a regula
tory element is to be coupled to a promoter, generally a

truncated (or minimal) promoter is used, for example, the
20

molecule. Alternatively, Well-knoWn and Widely accessible
polymerase chain reaction (PCR) technology is advanta
geously used to amplify sequences With signi?cant nucle
otide sequence homology to a target sequence.
It is understood that nucleic acid sequences other than the
EAS coding sequence disclosed in SEQ ID NO:7 Will
function as coding sequences synonymous With the exem
pli?ed EAS4 coding sequence. Nucleic acid sequences are
synonymous if the amino acid sequences encoded by those
nucleic acid sequences are the same. The degeneracy of the

Alternately, a cDNA library (in an expression vector) can
be screened With EAS-speci?c antibody, or EAS peptide

truncated 35S promoter of Cauli?oWer Mosaic Virus,
CaMV). Truncated versions of other constitutive promoters
can also be used to provide CAAT and TATA-homologous
regions; such promoter sequences can be derived from those
of A. tumefaciens T-DNA genes such as nos, ocs, and mas

25
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and plant virus genes such as the CaMV 19S gene. It Will be
understood that the goals of a skilled artisan Will determine

the choice of particular promoters used With the inducible
transcription regulatory sequences. It is further understood
that When a protein capable of generating a cell death
response is to be expressed, then there is preferably no basal

genetic code is Well-knoWn to the art; i.e., for many amino

transcriptional (and translational) expression in the absence

acids, there is more than one nucleotide triplet Which serves
as the codon for the amino acid. It is also Well-knoWn in the
biological arts that certain amino acid substitutions can be

of inducer. The minimiZation of basal expression is less

made in protein sequences Without affecting the function of
the protein. Generally, conservative amino acid substitutions

critical in applications for inducible gene expression Where
the gene product has no signi?cant toxicity to the plant cells
35

producing it.
A minimal promoter contains the DNA sequence signals
necessary for RNA polymerase binding and initiation of
transcription. For RNA polymerase II promoters, the pro

or substitutions of similar amino acids are tolerated Without

affecting protein function. Similar amino acids can be those
that are similar in siZe and/or charge properties, for example,

pairs of similar amino acids. Similarity betWeen amino acid

moter is identi?ed by a TATA-homologous sequence motif
about 20 to 50 bp upstream of the transcription start site and
a CAAT-homologous sequence motif about 50 to 120 bp

pairs has been assessed in the art in a number of Ways. For

upstream of the transcription start site. By convention, the

aspartate and glutamate and isoleucine and valine are both

40

example, Dayhoff et al. (1978) in Atlas of Protein Sequence
and Structure, Vol. 5, Suppl. 3, pp. 345—352, Which is

incorporated by reference herein, provides frequency tables

skilled artisan often numbers the nucleotides upstream of the
45

for amino acid substitutions Which can be employed as a

measure of amino acid similarity. Dayhoff et al.’s frequency

loW and does not respond either positively or negatively to
environmental or developmental signals in plant tissue. An
exemplary minimal promoter suitable for use in plants is the
truncated CaMV 35S promoter, Which contains the regions

tables are based on comparisons of amino acid sequences for

proteins having the same function from a variety of evolu
tionarily different sources.
Terpene cyclase genes can be found in solanaceous plants,
including N. tabacum and Hyoscyamus muticus, as disclosed

from —90 to +8 of the 35S gene.

The inducible transcription regulatory sequence

(qualitative transcription regulatory sequence) is localiZed to

herein, and in members of the mint family (Labitaceae) and
the Euphorbiaceae, including but not limited to those Which
have been demonstrated to contain sequences of signi?cant

the region betWeen —167 and —100 relative to the EAS4
55

homology, and in substantially all plants. Preferably, EAS4
homologs Will be selected from the Solanaceae. Such
sequences can be identi?ed by nucleic acid hybridiZation
experiments or When cloned in expression vectors, by cross
reaction to tobacco EAS-speci?c antibody, or any other

transcription initiation site (nucleotides 406 to 473, initiation
at nucleotide 573 in SEQ ID NO:2). It is understood that
there may be a plurality of sequence motifs Which respond

to particular stimuli. Operably linking this sequence directly
upstream of a minimal promoter functional in a plant cell
60

confers inducible expression of a coding sequence operably
fused just doWnstream of the promoter, e.g., a heterologous
coding sequence, and the skilled artisan understands spacing
requirements and other requirements for translational

65

sequence is preferably for an elicitin-like protein of a plant

means knoWn to the art, including the use of PCR technol

ogy carried out using oligonucleotides corresponding to

portions of SEQ ID NO:7, preferably in the region encoding
EAS. Antibody can be prepared after immuniZing an experi
mental animal With EAS puri?ed as described in Vogeli et al.
(1990) Plant Physiology 93:182—187 or using a peptide
conjugate, Where the amino acid sequence of the peptide is

transcription start With increasingly large numbers extend
ing upstream of (in the 5‘ direction) from the start site.
Generally, transcription directed by a minimal promoter is

expression of the coding sequence. The heterologous coding
pathogenic microorganism (e.g., a virus, bacterium or

fungus), for example, the sequence encoding the parA1 gene

